UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2016

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission File Number: 001-36743

Apple Inc.

(Exact name of Registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

(408) 996-1010

(Registrant s telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No

5,246,540,000 shares of common stock, par value $0.00001 per share, issued and outstanding as of January 20, 2017

Apple Inc.

Form 10-Q

For the Fiscal Quarter Ended December 31, 2016

TABLE OF CONTENTS

Page

Part I

Item 1.

Financial Statements

Item 2.

Management s Discussion and Analysis of Financial Condition and Results of Operations

22

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

32

Item 4.

Controls and Procedures

32

Part II

Item 1.

Legal Proceedings

33

Item 1A.

Risk Factors

33

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

43

Item 3.

Defaults Upon Senior Securities

43

Item 4.

Mine Safety Disclosures

43

Item 5.

Other Information

43

Item 6.

Exhibits

44

PART I FINANCIAL INFORMATION

Item 1.

Financial Statements

Apple Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In millions, except number of shares which are reflected in thousands and per share amounts)

Three Months Ended

December 31,

2016

December 26,

2015

Net sales

78,351

75,872

Cost of sales

48,175

45,449

Gross margin

30,176

30,423

Operating expenses:

Research and development

2,871

2,404

Selling, general and administrative

3,946

3,848

Total operating expenses

6,817

6,252

Operating income

23,359

24,171

Other income/(expense), net

821

402

Income before provision for income taxes

24,180

24,573

Provision for income taxes

6,289

6,212

Net income

17,891

18,361

Earnings per share:

Basic

3.38

3.30

Diluted

3.36

3.28

Shares used in computing earnings per share:

Basic

5,298,661

5,558,930

Diluted

5,327,995

5,594,127

Cash dividends declared per share

0.57

0.52

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(In millions)

Three Months Ended

December 31,

2016

December 26,

2015

Net income

17,891

18,361

Other comprehensive income/(loss):

Change in foreign currency translation, net of tax effects of $76 and $19, respectively

(375

(102

Change in unrealized gains/losses on derivative instruments:

Change in fair value of derivatives, net of tax benefit/(expense) of $(228) and $(38), respectively

1,468

287

Adjustment for net (gains)/losses realized and included in net income, net of tax expense/(benefit) of $(211) and $66, respectively

306

(445

Total change in unrealized gains/losses on derivative instruments, net of tax

1,774

(158

Change in unrealized gains/losses on marketable securities:

Change in fair value of marketable securities, net of tax benefit/(expense) of $989 and $508, respectively

(1,808

(922

Adjustment for net (gains)/losses realized and included in net income, net of tax expense/(benefit) of $(11) and $(26), respectively

20

47

Total change in unrealized gains/losses on marketable securities, net of tax

(1,788

(875

Total other comprehensive income/(loss)

(389

(1,135

Total comprehensive income

17,502

17,226

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In millions, except number of shares which are reflected in thousands and par value)

December 31,

2016

September 24,

2016

ASSETS:

Current assets:

Cash and cash equivalents

16,371

20,484

Short-term marketable securities

44,081

46,671

Accounts receivable, less an allowance of $53 in each period

14,057

15,754

Inventories

2,712

2,132

Vendor non-trade receivables

13,920

13,545

Other current assets

12,191

8,283

Total current assets

103,332

106,869

Long-term marketable securities

185,638

170,430

Property, plant and equipment, net

26,510

27,010

Goodwill

5,423

5,414

Acquired intangible assets, net

2,848

3,206

Other non-current assets

7,390

8,757

Total assets

331,141

321,686

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

38,510

37,294

Accrued expenses

23,739

22,027

Deferred revenue

7,889

8,080

Commercial paper

10,493

8,105

Current portion of long-term debt

3,499

3,500

Total current liabilities

84,130

79,006

Deferred revenue, non-current

3,163

2,930

Long-term debt

73,557

75,427

Other non-current liabilities

37,901

36,074

Total liabilities

198,751

193,437

Commitments and contingencies

Shareholders equity:

Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 5,255,423 and 5,336,166 shares issued and outstanding, respectively

32,144

31,251

Retained earnings

100,001

96,364

Accumulated other comprehensive income/(loss)

245

634

Total shareholders equity

132,390

128,249

Total liabilities and shareholders equity

331,141

321,686

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In millions)

Three Months Ended

December 31,

2016

December 26,

2015

Cash and cash equivalents, beginning of the period

20,484

21,120

Operating activities:

Net income

17,891

18,361

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation and amortization

2,987

2,954

Share-based compensation expense

1,256

1,078

Deferred income tax expense

1,452

1,592

Other

(274

110

Changes in operating assets and liabilities:

Accounts receivable, net

1,697

3,896

Inventories

(580

(102

Vendor non-trade receivables

(375

1,826

Other current and non-current assets

(1,446

(1,058

Accounts payable

2,460

(852

Deferred revenue

42

(29

Other current and non-current liabilities

1,946

(313

Cash generated by operating activities

27,056

27,463

Investing activities:

Purchases of marketable securities

(54,272

(47,836

Proceeds from maturities of marketable securities

6,525

3,514

Proceeds from sales of marketable securities

32,166

28,262

Payments made in connection with business acquisitions, net

(17

(86

Payments for acquisition of property, plant and equipment

(3,334

(3,612

Payments for acquisition of intangible assets

(86

(394

Payments for strategic investments

(126

Other

(104

(172

Cash used in investing activities

(19,122

(20,450

Financing activities:

Proceeds from issuance of common stock

Excess tax benefits from equity awards

178

224

Payments for taxes related to net share settlement of equity awards

(629

(597

Payments for dividends and dividend equivalents

(3,130

(2,969

Repurchases of common stock

(10,851

(6,863

Change in commercial paper, net

2,385

(1,240

Cash used in financing activities

(12,047

(11,444

Increase/(Decrease) in cash and cash equivalents

(4,113

(4,431

Cash and cash equivalents, end of the period

16,371

16,689

Supplemental cash flow disclosure:

Cash paid for income taxes, net

3,510

3,398

Cash paid for interest

497

396

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs, manufactures and markets mobile communication and media devices, personal computers and portable digital music players, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company s products and services include iPhone , iPad , Mac , iPod , Apple Watch , Apple TV , a portfolio of consumer and professional software applications, iOS, macOS , watchOS and tvOS operating systems, iCloud , Apple Pay and a variety of accessory, service and support offerings. The Company sells and delivers digital content and applications through the iTunes Store , App Store , Mac App Store, TV App Store, iBooks Store and Apple Music (collectively Digital Content and Services ). The Company sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of third-party Apple-compatible products, including application software and various accessories through its retail and online stores. The Company sells to consumers, small and mid-sized businesses and education, enterprise and government customers.

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. In the opinion of the Company s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements have been reclassified to conform to the current period s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's annual consolidated financial statements and the notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 24, 2016 (the 2016 Form 10-K ).

The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year 2017 will include 53 weeks and ends on September 30, 2017 and its fiscal year 2016 included 52 weeks and ended on September 24, 2016. A 14th week has been included in the first quarter of 2017, as is done every five or six years, to realign fiscal quarters with calendar quarters. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.

Earnings Per Share

Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased by employees under the Company s employee stock purchase plan, unvested restricted stock and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table shows the computation of basic and diluted earnings per share for the three months ended December 31, 2016 and December 26, 2015 (net income in millions and shares in thousands):

Three Months Ended

December 31,

2016

December 26,

2015

Numerator:

Net income

17,891

18,361

Denominator:

Weighted-average shares outstanding

5,298,661

5,558,930

Effect of dilutive securities

29,334

35,197

Weighted-average diluted shares

5,327,995

5,594,127

Basic earnings per share

3.38

3.30

Diluted earnings per share

3.36

3.28

Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings per share.

Note 2 Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of December 31, 2016 and September 24, 2016 (in millions):

December 31, 2016

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

9,359

9,359

9,359

Level 1 (1):

Money market funds

4,640

4,640

4,640

Mutual funds

1,004

(137

867

867

Subtotal

5,644

(137

5,507

4,640

867

Level 2 (2):

U.S. Treasury securities

48,431

47

(333

48,145

1,022

13,074

34,049

U.S. agency securities

4,284

(10

4,278

404

1,999

1,875

Non-U.S. government securities

7,574

79

(136

7,517

408

7,109

Certificates of deposit and time deposits

5,893

5,893

334

4,089

1,470

Commercial paper

3,750

3,750

536

3,214

Corporate securities

140,697

469

(737

140,429

76

20,283

120,070

Municipal securities

955

(9

946

111

835

Mortgage- and asset-backed securities

20,486

23

(243

20,266

36

20,230

Subtotal

232,070

622

(1,468

231,224

2,372

43,214

185,638

Total

247,073

622

(1,605

246,090

16,371

44,081

185,638

September 24, 2016

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

8,601

8,601

8,601

Level 1 (1):

Money market funds

3,666

3,666

3,666

Mutual funds

1,407

(146

1,261

1,261

Subtotal

5,073

(146

4,927

3,666

1,261

Level 2 (2):

U.S. Treasury securities

41,697

319

(4

42,012

1,527

13,492

26,993

U.S. agency securities

7,543

16

7,559

2,762

2,441

2,356

Non-U.S. government securities

7,609

259

(27

7,841

110

818

6,913

Certificates of deposit and time deposits

6,598

6,598

1,108

3,897

1,593

Commercial paper

7,433

7,433

2,468

4,965

Corporate securities

131,166

1,409

(206

132,369

242

19,599

112,528

Municipal securities

956

961

167

794

Mortgage- and asset-backed securities

19,134

178

(28

19,284

31

19,253

Subtotal

222,136

2,186

(265

224,057

8,217

45,410

170,430

Total

235,810

2,186

(411

237,585

20,484

46,671

170,430

(1)

Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities.

(2)

Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The maturities of the Company s long-term marketable securities generally range from one to five years.

The Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis. As of December 31, 2016, the Company does not consider any of its investments to be other-than-temporarily impaired.

Derivative Financial Instruments

The Company may use derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates.

To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.

To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. In addition, the Company may use non-derivative financial instruments, such as its foreign currency-denominated debt, as economic hedges of its net investments in certain foreign subsidiaries. In both of these cases, the Company designates these instruments as net investment hedges.

The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies.

The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company s term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company s hedged interest rate transactions as of December 31, 2016 are expected to be recognized within 10 years.

Cash Flow Hedges

The effective portions of cash flow hedges are recorded in accumulated other comprehensive income ( AOCI ) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net.

Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions.

Net Investment Hedges

The effective portions of net investment hedges are recorded in other comprehensive income ( OCI ) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net.

Fair Value Hedges

Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item.

Non-Designated Derivatives

Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. As a result, during the three months ended December 31, 2016, the Company recognized gains in net sales, cost of sales and other income/(expense), net of $273 million, $332 million and $508 million, respectively.

The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting treatment for these derivative instruments is based on its hedge designation. The following tables show the Company s derivative instruments at gross fair value as of December 31, 2016 and September 24, 2016 (in millions):

December 31, 2016

Fair Value of

Derivatives Designated

as Hedge Instruments

Fair Value of

Derivatives Not Designated

as Hedge Instruments

Total

Fair Value

Derivative assets (1):

Foreign exchange contracts

1,453

1,104

2,557

Interest rate contracts

186

186

Derivative liabilities (2):

Foreign exchange contracts

977

536

1,513

Interest rate contracts

331

331

10

September 24, 2016

Fair Value of

Derivatives Designated

as Hedge Instruments

Fair Value of

Derivatives Not Designated

as Hedge Instruments

Total

Fair Value

Derivative assets (1):

Foreign exchange contracts

518

153

671

Interest rate contracts

728

728

Derivative liabilities (2):

Foreign exchange contracts

935

134

1,069

Interest rate contracts

(1)

The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets.

(2)

The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets.

The following table shows the pre-tax gains and losses of the Company s derivative and non-derivative instruments designated as cash flow, net investment and fair value hedges in OCI and the Condensed Consolidated Statements of Operations for the three months ended December 31, 2016 and December 26, 2015 (in millions):

Three Months Ended

December 31,

2016

December 26,

2015

Gains/(Losses) recognized in OCI effective portion:

Cash flow hedges:

Foreign exchange contracts

1,727

326

Interest rate contracts

Total

1,734

334

Net investment hedges:

Foreign exchange contracts

Foreign currency debt

122

10

Total

122

10

Gains/(Losses) reclassified from AOCI into net income effective portion:

Cash flow hedges:

Foreign exchange contracts

(511

515

Interest rate contracts

(1

(4

Total

(512

511

Gains/(Losses) on derivative instruments:

Fair value hedges:

Interest rate contracts

(872

(111

Gains/(Losses) related to hedged items:

Fair value hedges:

Interest rate contracts

872

111

11

The following table shows the notional amounts of the Company s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of December 31, 2016 and September 24, 2016 (in millions):

December 31, 2016

September 24, 2016

Notional

Amount

Credit Risk

Amount

Notional

Amount

Credit Risk

Amount

Instruments designated as accounting hedges:

Foreign exchange contracts

40,526

1,453

44,678

518

Interest rate contracts

24,500

186

24,500

728

Instruments not designated as accounting hedges:

Foreign exchange contracts

57,144

1,104

54,305

153

The notional amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. The Company s exposure to credit loss and market risk will vary over time as currency and interest rates change. Although the table above reflects the notional and credit risk amounts of the Company s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.